Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies, Dr. Georgina Long explained in an interview with CURE.
Melanoma News
How Does MMS Compare With Conventional Excision for Hand and Foot Melanomas?
Conventional excision (CE) of hand and foot melanomas is associated with increased rates of reconstruction with positive margins, repeat excisions, and longer time to reconstruction compared with Mohs micrographic surgery (MMS), according to study findings published in the Journal of the American Academy of Dermatology.
Gene-Based Blood Test for Melanoma May Catch Early Signs of Cancer’s Return
Mdying tumor cells may accurately predict skin cancer recurrence, a new study shows.
Adjuvant Dabrafenib Plus Trametinib Deemed Promising for Stage IIIA Melanoma
Adjuvant treatment with dabrafenib and trametinib may be more effective than observation or adjuvant treatment with a PD-1 inhibitor in patients with stage IIIA melanoma, according to retrospective findings published in Annals of Oncology.